Stock Earnings

Question 1

What are Kazia Therapeutics Ltd's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Kazia Therapeutics Ltd has a total asset of $6, Net loss of $-20

Question 2

What are the key financial ratios for KZIA?

Accepted Answer

Kazia Therapeutics Ltd's Current ratio is 0.42, has a Net margin is 0, sales per share of $0.

Question 3

How is Kazia Therapeutics Ltd's revenue broken down by segment or geography?

Accepted Answer

Kazia Therapeutics Ltd largest revenue segment is Pharmaceutical, at a revenue of 27,200 in the most earnings release.For geography, Israel is the primary market for Kazia Therapeutics Ltd, at a revenue of 27,200.

Question 4

Is Kazia Therapeutics Ltd profitable?

Accepted Answer

no, according to the latest financial statements, Kazia Therapeutics Ltd has a net loss of $-20

Question 5

Does Kazia Therapeutics Ltd have any liabilities?

Accepted Answer

yes, Kazia Therapeutics Ltd has liability of 14

Question 6

How many outstanding shares for Kazia Therapeutics Ltd?

Accepted Answer

Kazia Therapeutics Ltd has a total outstanding shares of 809.41

Breakdown	TTM	06/30/2025	06/30/2024	06/30/2023	06/30/2022	06/30/2021
Revenue	0	0	2	0	0	15
Revenue Growth (YoY)	-100%	-100%	--	--	-100%	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	12	8	13	8	5	7
Research & Development	8	6	15	15	20	14
Operating Expenses	19	18	29	24	25	21
Other Non Operating Income (Expenses)	1	1	0	0	0	0
Pretax Income	-24	-22	-27	-20	-25	-8
Income Tax Expense	-1	-1	0	0	0	0
Net Income	-22	-20	-26	-20	-25	-8
Net Income Growth	-21%	-23%	30%	-20%	213%	-33%
Shares Outstanding (Diluted)	1,560.21	547.94	52.73	3.68	2.64	2.35
Shares Change (YoY)	267%	939%	1,331%	39%	13%	54%
EPS (Diluted)	-0.01	-0.03	-0.5	-5.55	-9.44	-3.57
EPS Growth	-70%	-93%	-91%	-41%	164%	-56%
Free Cash Flow	-1	-13	-9	-15	-22	-9
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	-1,350%	0%	0%	-40%
Profit Margin	0%	0%	-1,300%	0%	0%	-53.33%
Free Cash Flow Margin	0%	0%	-450%	0%	0%	-60%
EBITDA	--	-18	-26	--	--	--
EBITDA Margin	--	0%	-1,300%	--	--	--
D&A For EBITDA	--	0	1	--	--	--
EBIT	-19	-18	-27	-24	-25	-6
EBIT Margin	0%	0%	-1,350%	0%	0%	-40%
Effective Tax Rate	4.16%	4.54%	0%	0%	0%	0%

Kazia Therapeutics Ltd (KZIA) Financial

KZIA Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is KZIA?

KZIA Income

Follow-Up Questions